JDD HighlightsSkin of Color

View the Latest Skin of Color, Anti-Aging, Aesthetic, and Medical Dermatology Articles Now

By June 30, 2020March 5th, 2026No Comments

Dermatology News

JDD Highlights

The July issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin of Color, with special features on Anti-Aging, Aesthetic, and Medical Dermatology.
Read the JDD Now

Skin of Color, Anti-Aging, Aesthetic, and Medical Dermatology

The July issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin of Color, with special features on Anti-Aging, Aesthetic, and Medical Dermatology.

Article Highlights

Editor's Picks

You May Also Like

Journal of Drugs in Dermatology JDD Article about Brodalumab’s 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence

Brodalumab’s 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence

| Featured Articles, Latest News, Psoriasis | No Comments
Updated long term and real world evidence on efficacy and safety This is a must-read JDD article on brodalumab in plaque psoriasis. The review summarizes long term clinical trial findings,…
Journal of Drugs in Dermatology JDD Article about JDD’s Social and Technology Microsite

JDD’s Social and Technology Microsite

| Featured Articles, Latest News, Social and Technology | No Comments
What Every Dermatologist Should Know About Social Media & Technology - A JDD Microsite Introduction JDD has its own microsite dedicated to Social & Technology topics, from exploring digital platforms,…
Journal of Drugs in Dermatology JDD Article about Dive Deeper Into Hidradenitis Suppurativa

Dive Deeper Into Hidradenitis Suppurativa

| Featured Articles, Hidradenitis Suppurativa, Latest News | No Comments
Dive into JDD’s hidradenitis suppurativa resources! Hidradenitis suppurativa (HS)  is common, devastating, and often underdiagnosed - and in the past decade the therapeutic toolbox and clinic pathways have expanded rapidly.…

Leave a Reply